Loading...
Loading...
Browse all stories on DeepNewz
VisitWill the court approve Purdue Pharma's revised $6.5B settlement by June 2025?
Yes • 50%
No • 50%
Court rulings or official announcements from the involved legal parties
Sacklers Increase Purdue Pharma Bankruptcy Settlement Contribution to $6.5 Billion from $6 Billion for Opioid Lawsuits
Jan 13, 2025, 11:35 AM
Members of the Sackler family, owners of Purdue Pharma, have agreed to increase their total contribution to a new bankruptcy settlement related to opioid lawsuits. The revised contribution will amount to approximately $6.5 billion, up from $6 billion under a previous plan. This adjustment comes as part of ongoing legal efforts to address the financial repercussions of the opioid crisis. Reports indicate that the Sacklers' overall wealth has increased since Purdue's bankruptcy filing, attributed to the appreciation of their investment assets and financial holdings.
View original story
Johnson & Johnson • 25%
Other • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
No significant actions • 25%
File for bankruptcy again • 25%
Rebrand or restructure • 25%
Reach new settlements with other firms • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
U.S. Department of Justice • 25%
Securities and Exchange Commission • 25%
Other • 25%
Federal Trade Commission • 25%
Yes • 50%
No • 50%
More negative • 25%
Mixed opinions • 25%
Unchanged • 25%
Less negative • 25%
No states receive funds • 25%
All states receive funds • 25%
Most states receive funds • 25%
Some states receive funds • 25%